Avidity Partners Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-578,100
Closed -$27.3M 125
2020
Q4
$27.3M Buy
578,100
+333,400
+136% +$15.5M 0.89% 42
2020
Q3
$11.4M Buy
+244,700
New +$8.4M 0.53% 45

Other funds holding ZYME

Avidity Partners Management's ZYME Position: Q1 2021 in Review

Avidity Partners Management sold out of Zymeworks (ZYME) in Q1 2021, closing a stake of 578,100 shares — an estimated $27.3M sold.

Avidity Partners Management first reported a position in ZYME in Q3 2020 and held it in 2 quarters. The position peaked at $27.3M in Q4 2020. 125 funds tracked by Wall St. Rank hold ZYME as of Q1 2021.

  • Avidity Partners Management reported no remaining Zymeworks position as of Q1 2021 after selling out during the quarter.
  • Avidity Partners Management sold 578,100 Zymeworks shares in Q1 2021, an estimated $27.3M.
  • Avidity Partners Management first reported a position in Zymeworks in Q3 2020 and held it in 2 quarters.
  • Avidity Partners Management's Zymeworks position peaked at $27.3M in Q4 2020.
  • 125 funds tracked by Wall St. Rank held Zymeworks as of Q1 2021.

Based on Avidity Partners Management's 13F filing for Q1 2021, filed 17 May 2021.